Luis Souhami

Summary

Affiliation: McGill University
Country: Canada

Publications

  1. doi Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer
    Eric Tran
    Department of Radiation Oncology, McGill University Health Center, Montreal, Quebec H3G 1A4, Canada
    Am J Clin Oncol 32:333-7. 2009
  2. pmc Impact of the duration of adjuvant hormonal therapy in patients with locally advanced prostate cancer treated with radiotherapy: a secondary analysis of RTOG 85-31
    Luis Souhami
    Montreal General Hospital, 1650 Cedar Ave, Montreal, Quebec H3G 1A4, Canada
    J Clin Oncol 27:2137-43. 2009
  3. ncbi Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol
    Luis Souhami
    Department of Oncology, Division of Radiation Oncology, McGill University, Montreal, Quebec, Canada
    Int J Radiat Oncol Biol Phys 60:853-60. 2004
  4. ncbi Long-term results of high-dose rate brachytherapy in cervix cancer using a small number of fractions
    Luis Souhami
    Department of Oncology, Division of Radiation Oncology, McGill University, Montreal, Quebec, Canada
    Gynecol Oncol 97:508-13. 2005
  5. doi Timing of salvage hormonal therapy in prostate cancer patients with unfavorable prognosis treated with radiotherapy: a secondary analysis of Radiation Therapy Oncology Group 85-31
    Luis Souhami
    McGill University Health Centre, Montreal, Quebec, Canada
    Int J Radiat Oncol Biol Phys 78:1301-6. 2010
  6. doi Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiation therapy in the treatment of intermediate-risk prostate cancer - long term results
    Fabio L Cury
    Department of Radiation Oncology, McGill University Health Centre, Montreal, QC, Canada
    Int J Radiat Oncol Biol Phys 82:1417-23. 2012
  7. doi Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis
    Valerie Panet-Raymond
    Department of Oncology, Division of Radiation Oncology, McGill University, Montreal, QC, Canada
    Int J Radiat Oncol Biol Phys 73:473-8. 2009
  8. ncbi Intermittent androgen ablation in patients with biochemical failure after pelvic radiotherapy for localized prostate cancer
    Fabio L B Cury
    Department of Oncology, Division of Radiation Oncology, McGill University, Montreal, Quebec, Canada
    Int J Radiat Oncol Biol Phys 64:842-8. 2006
  9. doi Hypofractionated radiation therapy (66 Gy in 22 fractions at 3 Gy per fraction) for favorable-risk prostate cancer: long-term outcomes
    Nita Patel
    Department of Radiation Oncology, McGill University Health Centre, Montreal, Quebec, Canada
    Int J Radiat Oncol Biol Phys 86:534-9. 2013
  10. pmc Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer
    Sergio L Faria
    Department of Radiation Oncology, McGill University Health Centre, Montreal, Canada
    Radiat Oncol 1:42. 2006

Detail Information

Publications65

  1. doi Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer
    Eric Tran
    Department of Radiation Oncology, McGill University Health Center, Montreal, Quebec H3G 1A4, Canada
    Am J Clin Oncol 32:333-7. 2009
    ..To report the long-term results of bladder conservation strategies in elderly patients with muscle-invasive bladder cancer and evaluate the different factors affecting locoregional control and patient survival...
  2. pmc Impact of the duration of adjuvant hormonal therapy in patients with locally advanced prostate cancer treated with radiotherapy: a secondary analysis of RTOG 85-31
    Luis Souhami
    Montreal General Hospital, 1650 Cedar Ave, Montreal, Quebec H3G 1A4, Canada
    J Clin Oncol 27:2137-43. 2009
    ..We correlated duration of adjuvant hormonal therapy and outcomes among patients who prematurely discontinued hormonal therapy...
  3. ncbi Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol
    Luis Souhami
    Department of Oncology, Division of Radiation Oncology, McGill University, Montreal, Quebec, Canada
    Int J Radiat Oncol Biol Phys 60:853-60. 2004
    ..We investigated the effect of stereotactic radiosurgery (SRS) added to conventional external beam radiation therapy (EBRT) with carmustine (BCNU) on the survival of patients with GBM...
  4. ncbi Long-term results of high-dose rate brachytherapy in cervix cancer using a small number of fractions
    Luis Souhami
    Department of Oncology, Division of Radiation Oncology, McGill University, Montreal, Quebec, Canada
    Gynecol Oncol 97:508-13. 2005
    ..To evaluate the long-term treatment outcome of patients with carcinoma of the cervix treated with high dose rate brachytherapy (HDRB) using a small number of fractions...
  5. doi Timing of salvage hormonal therapy in prostate cancer patients with unfavorable prognosis treated with radiotherapy: a secondary analysis of Radiation Therapy Oncology Group 85-31
    Luis Souhami
    McGill University Health Centre, Montreal, Quebec, Canada
    Int J Radiat Oncol Biol Phys 78:1301-6. 2010
    ..RT plus adjuvant androgen suppression for life in unfavorable-prognosis carcinoma of the prostate. We examined the impact of early initiation of salvage hormonal therapy (HT) in relapsing patients randomized to RT alone arm...
  6. doi Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiation therapy in the treatment of intermediate-risk prostate cancer - long term results
    Fabio L Cury
    Department of Radiation Oncology, McGill University Health Centre, Montreal, QC, Canada
    Int J Radiat Oncol Biol Phys 82:1417-23. 2012
    ..We present the long-term results of a cohort of patients with intermediate-risk prostate cancer (PC) treated with single-fraction high-dose-rate brachytherapy (HDRB) combined with hypofractionated external beam radiation therapy (HypoRT)...
  7. doi Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis
    Valerie Panet-Raymond
    Department of Oncology, Division of Radiation Oncology, McGill University, Montreal, QC, Canada
    Int J Radiat Oncol Biol Phys 73:473-8. 2009
    ..In an attempt to improve results, we have begun a program of accelerated hypofractionated intensity-modulated radiotherapy (hypo-IMRT) with concomitant and adjuvant temozolomide (TMZ)...
  8. ncbi Intermittent androgen ablation in patients with biochemical failure after pelvic radiotherapy for localized prostate cancer
    Fabio L B Cury
    Department of Oncology, Division of Radiation Oncology, McGill University, Montreal, Quebec, Canada
    Int J Radiat Oncol Biol Phys 64:842-8. 2006
    ..To assess the efficacy of intermittent androgen ablation (IAA) in patients with biochemical failure after radiotherapy for prostate cancer...
  9. doi Hypofractionated radiation therapy (66 Gy in 22 fractions at 3 Gy per fraction) for favorable-risk prostate cancer: long-term outcomes
    Nita Patel
    Department of Radiation Oncology, McGill University Health Centre, Montreal, Quebec, Canada
    Int J Radiat Oncol Biol Phys 86:534-9. 2013
    ..To report long-term outcomes of low- and intermediate-risk prostate cancer patients treated with high-dose hypofractionated radiation therapy (HypoRT)...
  10. pmc Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer
    Sergio L Faria
    Department of Radiation Oncology, McGill University Health Centre, Montreal, Canada
    Radiat Oncol 1:42. 2006
    ..It is more convenient for the patients and reduces health care costs. This study reports our results on patients with medically inoperable, early stage, non-small cell lung cancer (NSCLC) treated with hypofractionation...
  11. ncbi Is there a detrimental effect of waiting for radiotherapy for patients with localized prostate cancer?
    Sergio L Faria
    Department of Oncology, Division of Radiation Oncology, McGill University Montreal, QC, Canada
    Am J Clin Oncol 29:463-7. 2006
    ..To evaluate a possible deleterious effect of waiting time to radiotherapy on the biochemical relapse (BR) of patients with localized prostate cancer...
  12. ncbi Analysis of prognostic factors and patterns of recurrence in patients with pathologic stage III endometrial cancer
    Samir Patel
    Division of Radiation Oncology, Department of Oncology, McGill University, Montreal, Quebec, Canada
    Int J Radiat Oncol Biol Phys 68:1438-45. 2007
    ..To retrospectively assess prognostic factors and patterns of recurrence in patients with pathologic Stage III endometrial cancer...
  13. ncbi Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer
    Vera Hirsh
    Division of Medical Oncology, Department of Medicine, McGill University Health Center, Montreal, Quebec, Canada
    J Thorac Oncol 2:927-32. 2007
    ..The role of induction chemotherapy with carboplatin/gemcitabine regimen has not been established in stage III NSCLC...
  14. ncbi Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome
    Dominik Denschlag
    Division of Gynecological Oncology, Department of Obstetrics and Gynecology, McGill University, Montreal, QC, Canada
    Am J Obstet Gynecol 196:546.e1-7. 2007
    ..We evaluated prognostic factors, treatment-related survival, and routinely used assessments for identifying stage III disease before the operation...
  15. doi Hypofractionated radiotherapy for favorable risk prostate cancer
    Nicholas Rene
    Department of Radiation Oncology, McGill University Health Centre, Montreal, Quebec, Canada
    Int J Radiat Oncol Biol Phys 77:805-10. 2010
    ..However, there is little experience with the use of hypofractionation delivering a high biologically equivalent dose. We report our experience with high-dose hypofractionated radiotherapy...
  16. doi Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone
    Sergio Faria
    Department of Radiation Oncology, McGill University Health Centre, Montreal, Canada
    Radiother Oncol 101:486-9. 2011
    ..Hypofractionated external beam radiotherapy (HyRT) is a short and convenient alternative treatment. We report our results of HyRT in intermediate-risk patients...
  17. ncbi No immediate treatment after biochemical failure in patients with prostate cancer treated by external beam radiotherapy
    Sergio L Faria
    Department of Radiation Oncology, McGill University Health Centre, Montreal, Quebec, Canada
    Urology 67:142-6. 2006
    ..Our general policy has been to follow-up patients with low prostate-specific antigen (PSA) levels and a long PSA doubling time without therapy. We report our experience using such an approach...
  18. doi Contemporary outcome and management of patients who had an aborted cystectomy due to unresectable bladder cancer
    Faysal A Yafi
    Division of Urology, McGill University Health Center, Montreal, Quebec, Canada
    Urol Oncol 29:309-13. 2011
    ..Aborted cystectomy due to unresectable disease is not uncommon in patients with bladder cancer. Our aim was to review the outcome of these patients and evaluate various prognostic variables...
  19. doi Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma
    Kevin Petrecca
    Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, 3801 University Ave, Suite 109, Montreal, QC, H3A 2B4, Canada
    J Neurooncol 111:19-23. 2013
    ..We found that even in cases of complete resection of the gadolinium-enhancing portion of GBM 85 % of recurrences are localized to the resection margin...
  20. doi Prostate gland edema after single-fraction high-dose rate brachytherapy before external beam radiation therapy
    Fabio L Cury
    Division of Radiation Oncology, Department of Oncology, McGill University Health Centre, Montreal, Quebec, Canada
    Brachytherapy 9:208-12. 2010
    ..We assessed prostate gland volumetric change after single-fraction HDRB and its impact on definition of treatment volume for EBRT...
  21. ncbi Ultrasound-based image guided radiotherapy for prostate cancer: comparison of cross-modality and intramodality methods for daily localization during external beam radiotherapy
    Fabio L B Cury
    Department of Oncology, Division of Radiation Oncology, McGill University, Montreal, Quebec, Canada
    Int J Radiat Oncol Biol Phys 66:1562-7. 2006
    ..To compare two different ultrasound-based verification systems for prostate alignment during daily external beam radiation therapy (EBRT) for localized prostate cancer...
  22. ncbi An assessment of PTV margin definitions for patients undergoing conformal 3D external beam radiation therapy for prostate cancer based on an analysis of 10,327 pretreatment daily ultrasound localizations
    M Esmeralda Ramos Poli
    Department of Medical Physics, McGill University Health Centre, Montreal, Quebec, Canada
    Int J Radiat Oncol Biol Phys 67:1430-7. 2007
    ....
  23. ncbi Long-term results of high-dose-rate brachytherapy in the primary treatment of medically inoperable stage I-II endometrial carcinoma
    Tamim M Niazi
    Department of Oncology, Division of Radiation Oncology, McGill University, Montreal, Quebec, Canada
    Int J Radiat Oncol Biol Phys 63:1108-13. 2005
    ..The goal of this study was to update our experience of high-dose-rate brachytherapy (HDRB), with or without external-beam irradiation (EBRT), for such patients...
  24. doi Hypofractionated intensity modulated radiation therapy in combined modality treatment for bladder preservation in elderly patients with invasive bladder cancer
    Guy Anne Turgeon
    Department of Oncology, Division of Radiation Oncology, McGill University Health Centre, Montreal, Quebec, Canada
    Int J Radiat Oncol Biol Phys 88:326-31. 2014
    ..To review our experience with bladder-preserving trimodality treatment (TMT) using hypofractionated intensity modulated radiation therapy (IMRT) for the treatment of elderly patients with muscle-invasive bladder cancer...
  25. doi Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance
    Mohammed Al Otaibi
    Department of Surgery, McGill University Health Center, Montreal, Quebec, Canada
    Cancer 113:286-92. 2008
    ..The impact of repeat biopsy after diagnosis was examined in a cohort of men with prostate cancer on AS...
  26. ncbi Biochemical failure as single abnormality in patients with prostate cancer following radical treatment with external radiotherapy: follow-up without immediate treatment
    Sergio L Faria
    Department of Radio Oncology, McGill University, Montreal General Hospital, Montreal, Quebec, Canada
    Int Braz J Urol 30:289-95; discussion 295. 2004
    ..The guideline in our Department of Radiotherapy has been to follow up, with no initial therapy, cases with low PSA and short PSA doubling time. The present study reports this experience...
  27. ncbi Variations in PSA doubling time in patients with prostate cancer on "watchful waiting": value of short-term PSADT determinations
    Phillip L Ross
    Division of Urology, McGill University, Montreal, Quebec, Canada
    Urology 64:323-8. 2004
    ..Our aim was to determine the correlation between short-term PSADT measurements and long-term PSADT among men with prostate cancer on observation...
  28. doi A dosimetric comparison of two high-dose-rate brachytherapy planning systems in cervix cancer: standardized template planning vs. computerized treatment planning
    Hassisen Patone
    Department of Oncology, McGill University Health Center, 1650 Cedar Avenue, Montreal, Quebec, Canada
    Brachytherapy 7:254-9. 2008
    ..We performed a dosimetric comparison of STP and CTP to determine dose differences at point A and the International Commission on Radiation Units and Measurements Report 38 bladder and rectal reference points...
  29. ncbi Impact of FDG-PET/CT on radiotherapy volume delineation in non-small-cell lung cancer and correlation of imaging stage with pathologic findings
    Sergio L Faria
    Department of Radiation Oncology, McGill University Health Centre, Montreal, QC, Canada
    Int J Radiat Oncol Biol Phys 70:1035-8. 2008
    ..We performed a study to evaluate the impact of FDG-PET/CT on the radiotherapy volume delineation compared with CT without using any mathematical algorithm and to correlate the findings with the pathologic examination findings...
  30. doi Cone beam CT-based three-dimensional planning in high-dose-rate brachytherapy for cervical cancer
    Hani Al-Halabi
    Department of Radiation Oncology, McGill University Health Centre, Montreal, Quebec, Canada
    Int J Radiat Oncol Biol Phys 77:1092-7. 2010
    ....
  31. ncbi Radiation therapy and androgen deprivation in the management of high risk prostate cancer
    Alan Dal Pra
    Division of Radiation Oncology, Department of Oncology, McGill University Health Centre, Montreal, Quebec, Canada
    Int Braz J Urol 37:161-75; discussion 176-9. 2011
    ..This article critically reviews the data on the use of RT combined with androgen deprivation for the treatment of high-risk prostate cancer with emphasis on the results of phase 3 trials...
  32. doi Low-grade oligodendroglioma: an indolent but incurable disease? Clinical article
    Hamdy El-Hateer
    Department of Radiation Oncology, McGill University Health Center, Montreal, Quebec, Canada
    J Neurosurg 111:265-71. 2009
    ..The authors reviewed their institutional experience with pure low-grade oligodendroglioma (LGO), correlating outcomes with several variables of possible prognostic values...
  33. ncbi The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial
    Khalil Sultanem
    Department of Oncology, Division of Radiation Oncology, McGill University, Montreal, Quebec, Canada
    Int J Radiat Oncol Biol Phys 58:247-52. 2004
    ..We report our preliminary results using hypofractionated intensity-modulated accelerated radiotherapy regimen in the treatment of patients with GBM...
  34. doi Reporting late rectal toxicity in prostate cancer patients treated with curative radiation treatment
    Sergio L Faria
    Department of Radiation Oncology, McGill University Health Centre, Montreal, Canada
    Int J Radiat Oncol Biol Phys 72:777-81. 2008
    ..However, comparing results of late toxicity may not be straightforward. This article reviews the complexity of reporting long-term side effects by using data for patients treated in our institution with hypofractionated irradiation...
  35. doi Chemosensitized radiosurgery for recurrent brain metastases
    David Roberge
    Department of Radiation Oncology, Montreal General Hospital, Montreal, QC, Canada
    J Neurooncol 110:265-70. 2012
    ..2 %). Temozolomide, at doses up to 200 mg/(m(2) day) × 5 days, prior to SRS is well tolerated, with no dose-limiting toxicities in patients with recurrent brain metastases. Local control of target lesions was >80 %...
  36. ncbi Silver leaf nylon dressing to prevent radiation dermatitis in patients undergoing chemotherapy and external beam radiotherapy to the perineum
    Te Vuong
    Department of Radiation Oncology, McGill University Health Centre, Montreal, Quebec, Canada
    Int J Radiat Oncol Biol Phys 59:809-14. 2004
    ..The purpose of this study was to evaluate the value of SLND in preventing radiation dermatitis in patients undergoing radiotherapy to target volumes that included the perineum and concurrent chemotherapy...
  37. doi Psychosocial adjustment of men during the first year of prostate cancer
    Helene Ezer
    School of Nursing, McGill University, Montreal, Quebec, Canada
    Cancer Nurs 35:141-7. 2012
    ..The psychosocial dimension of prostate cancer has received increased attention over the past 2 decades...
  38. doi Local correlation between monte-carlo dose and radiation-induced fibrosis in lung cancer patients
    Gabriela Stroian
    Medical Physics Unit, McGill University, Montreal General Hospital, QC, Canada
    Int J Radiat Oncol Biol Phys 70:921-30. 2008
    ..To present a new method of evaluating the correlation between radiotherapy (RT)-induced fibrosis and the local dose delivered to non-small-cell lung cancer patients...
  39. ncbi Conformal preoperative endorectal brachytherapy treatment for locally advanced rectal cancer: early results of a phase I/II study
    Te Vuong
    Department of Radiation Oncology, McGill University Health Centre, Montreal, Quebec, Canada H3G 1A4
    Dis Colon Rectum 45:1486-93; discussion 1493-5. 2002
    ..The purpose of the current study was to assess the efficacy and the toxicity of endorectal high dose-rate brachytherapy as a preoperative downstaging treatment modality...
  40. ncbi Tumor bed radiosurgery following resection of brain metastases: a review
    David Roberge
    Department of Oncology, Division of Radiation Oncology, McGill University, 1650 Cedar Avenue, Montreal, QC H3G 1A4, Canada
    Technol Cancer Res Treat 9:597-602. 2010
    ..The procedure appears well tolerate with approximately a 5% risk of late radiation necrosis. Prospective data is lagging behind clinical practice and plans for prospective trials are discussed...
  41. ncbi Long-term results of para-aortic irradiation for patients with stage I seminoma of the testis
    Tamim M Niazi
    Department of Oncology, Division of Radiation Oncology, McGill University Health Center, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada
    Int J Radiat Oncol Biol Phys 61:741-4. 2005
    ..In this article, we report the long-term results of our prospective evaluation of para-aortic irradiation only for such patients...
  42. doi Stereotactic radiosurgery in the management of brain metastases from primary thyroid cancers
    Daniel M Bernad
    Department of Radiation Oncology, McGill University Health Centre Montreal General Hospital, 1650 Cedar Avenue, Montreal, QC, H3G 1A4, Canada
    J Neurooncol 98:249-52. 2010
    ..It is unclear as to whether current prognostic indices are relevant to this patient population...
  43. doi Whole-brain radiotherapy and tumor bed radiosurgery following resection of solitary brain metastases
    David Roberge
    Department of Radiation Oncology, McGill University Health Centre Montreal General Hospital, QC, Canada
    J Neurooncol 95:95-9. 2009
    ..Radiosurgery can be safely added to WBRT as an adjuvant treatment following resection of a single brain metastasis. In our retrospective series, this combination treatment produced a high rate of local control...
  44. doi A dosimetric evaluation of dose escalation for the radical treatment of locally advanced vulvar cancer by intensity-modulated radiation therapy
    Monique C W M Bloemers
    Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Med Dosim 37:310-3. 2012
    ..IMRT for vulvar cancer is feasible and an attractive option for dose escalation studies...
  45. ncbi Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin
    Alexandre I Belenkov
    Department of Oncology, Division of Radiation Oncology, Montreal General Hospital, Montreal, Quebec, Canada
    Mol Cancer Ther 3:1525-32. 2004
    ..Our findings indicate that rhEPO result in a significant, JAK2-dependent, in vitro resistance to ionizing radiation and to cisplatin in the human cancer cells lines studied in this report...
  46. ncbi Tolerance of radiotherapy and chemotherapy in elderly patients with bladder cancer
    John R Goffin
    McGill University Health Centre, Montreal General Hospital, Montreal, Quebec, Canada
    Am J Clin Oncol 27:172-7. 2004
    ..Our study shows that bladder-sparing radiotherapy with concurrent chemotherapy is feasible in patients 70 or more years of age, and should be considered for such patients if they are inoperable or strongly wish to avoid cystectomy...
  47. ncbi Killing two birds with one stone: a dosimetric study of dual target radiosurgery using a single isocenter
    David Roberge
    Department of Oncology, Division of Radiation Oncology, McGill University, Montreal, Quebec, H3G 1A4, Canada
    Technol Cancer Res Treat 5:613-7. 2006
    ....
  48. doi Development and impact evaluation of an e-learning radiation oncology module
    Joanne Alfieri
    Department of Radiation Oncology, McGill University Health Centre, Montreal, QC, Canada
    Int J Radiat Oncol Biol Phys 82:e573-80. 2012
    ..A web-based interactive module designed to improve residents' knowledge and application of key anatomy concepts pertinent to radiotherapy treatment planning was developed, and its effectiveness was assessed...
  49. ncbi Adaptation of wives to prostate cancer following diagnosis and 3 months after treatment: a test of family adaptation theory
    Helene Ezer
    School of Nursing, McGill University, Montreal, Canada H3A 2A7
    Int J Nurs Stud 43:827-38. 2006
    ..Factors predicting women's adaptation to prostate cancer have not been examined...
  50. ncbi Stereotactic radiosurgery in the management of intracranial gliomas
    David Roberge
    Division of Radiation Oncology, McGill University, Montreal General Hospital, 1650 Cedar Ave, Montreal, QC, Canada H3G 1A4
    Technol Cancer Res Treat 2:117-25. 2003
    ..For a very select group of patients with small recurrent lesions, F-SRT may represent a safe, reasonable treatment...
  51. ncbi The prostate cancer risk stratification project: database construction and risk stratification outcome analysis
    George Rodrigues
    From the aDepartment of Radiation Oncology, London Health Sciences Centre, London, Ontario bDepartment of Radiation Oncology, Juravinski Cancer Centre, Hamilton, Ontario cRadiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario dDepartment of Radiation Oncology, Kingston Regional Cancer Centre, Kingston, Ontario eDepartment of Radiation Oncology, Montreal General Hospital, Montreal, Quebec fDepartment of Radiation Oncology, Kelowna General Hospital, Kelowna, British Columbia gDepartment of Radiation Oncology, L Hôtel Dieu de Québec, Quebec City, Quebec hDepartment of Radiation Oncology, British Columbia Cancer Agency Vancouver Centre, Vancouver, British Columbia, Canada
    J Natl Compr Canc Netw 12:60-9. 2014
    ..The construction of a pan-Canadian database has informed important prostate cancer radiotherapy outcomes and risk stratification. ..
  52. pmc Volumetric measurement of vestibular schwannoma tumour growth following partial resection: predictors for recurrence
    Siavosh Vakilian
    Department of Radiation Oncology, McGill University Health Centre, Montreal, Canada
    J Neurol Surg B Skull Base 73:117-20. 2012
    ..Volumetric measurements appear to be superior to two-dimensional measurements in documenting VS growth and patients with residual tumors >2.5 cm(3) have a significantly higher rate of recurrence...
  53. ncbi Post-renal acute renal failure during pelvis irradiation for prostate cancer
    Marc David
    Department of Radiation Oncology, McGill University, Montreal, Quebec, Canada
    Can J Urol 9:1599-601. 2002
    ..To our knowledge, this complication has never been described previously. Given the thrust in prostate cancer treatment toward dose escalation this complication could become more frequent...
  54. ncbi Utility of PSA doubling time in follow-up of untreated patients with localized prostate cancer
    Andrew J Stephenson
    Department of Surgery Urology, McGill University, Montreal, Ontario, Canada
    Urology 59:652-6. 2002
    ..To evaluate the prostate-specific antigen (PSA) changes and the ability of PSA doubling time (PSADT) to predict disease progression in untreated patients with clinically localized prostate cancer...
  55. ncbi Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancer
    Hak Choy
    Vanderbilt University Medical Center, Nashville, TN, USA
    J Clin Oncol 23:5918-28. 2005
    ....
  56. ncbi On the selection of optimization parameters for an inverse treatment planning replacement of a forward planning technique for prostate cancer
    Dimitre H Hristov
    Department of Oncology, King Faisal Specialist Hospital and Research Center, P O Box 40047, Jeddah 21499, MBC J64, Kingdom of Saudi Arabia
    J Appl Clin Med Phys 3:200-11. 2002
    ....
  57. ncbi Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402
    Gregory Cairncross
    University of Calgary, Calgary, Alberta, Canada E mail
    J Clin Oncol 24:2707-14. 2006
    ..Furthermore, better outcomes in AO have been associated with 1p and 19q allelic loss...
  58. ncbi A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023
    Robert Cardinale
    Medical College of Virginia Virginia Commonwealth University, Richmond, VA, USA
    Int J Radiat Oncol Biol Phys 65:1422-8. 2006
    ....
  59. ncbi Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases
    Minesh P Mehta
    University of Wisconsin Madison, Department Human Oncology Radiation Oncology, 53792, USA
    J Clin Oncol 21:2529-36. 2003
    ....
  60. ncbi Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
    David W Andrews
    Department of Neurosurgery, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA
    Lancet 363:1665-72. 2004
    ..We aimed to assess whether stereotactic radiosurgery provided any therapeutic benefit in a randomised multi-institutional trial directed by the Radiation Therapy Oncology Group (RTOG)...
  61. ncbi The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma
    May N Tsao
    The American Society for Therapeutic Radiology and Oncology, Fairfax, VA 22033, USA
    Int J Radiat Oncol Biol Phys 63:47-55. 2005
    ..To systematically review the evidence for the use of stereotactic radiosurgery or stereotactic fractionated radiation therapy in adult patients with malignant glioma...
  62. ncbi The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases
    Minesh P Mehta
    The American Society for Therapeutic Radiology and Oncology, Fairfax, VA 22033, USA
    Int J Radiat Oncol Biol Phys 63:37-46. 2005
    ..To systematically review the evidence for the use of stereotactic radiosurgery in adult patients with brain metastases...
  63. ncbi Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial
    Bradley J Monk
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Chao Family Comprehensive Cancer Center, University of California, Irvine Medical Center, 101 The City Drive, Building 23, Room 107, Orange, CA 92868, USA
    Gynecol Oncol 96:721-8. 2005
    ....
  64. ncbi Concurrent chemotherapy and hypofractionated twice-daily radiotherapy in cervical cancer patients with stage IIIB disease and bilateral parametrial involvement: a phase I-II study
    Celia M Viegas
    Department ofRadiation Oncology, Instituto Nacional de Cancer, Rio de Janeiro, Brazil
    Int J Radiat Oncol Biol Phys 60:1154-9. 2004
    ..The purpose of this study was to evaluate the results of treatment (toxicity, survival, and patterns of failure) using this novel approach...
  65. ncbi Prostate cancer radiotherapy 2002: the way forward
    Himu Lukka
    Juravinski Cancer Centre, 699 Concession Street, Hamilton, Ontario L8V 5C2, Canada
    Can J Urol 12:2521-31. 2005
    ..Results from ongoing clinical trials will provide insight into these questions and will assist in the design of future clinical trials...